Treatment Outcomes in Black and White Children With Cancer: Results From the SEER Database and St Jude Children's Research Hospital, 1992 Through 2007
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Purpose: Treatment outcome for black patients with cancer has been significantly worse than for their white counterparts. We determined whether recent improved treatment had narrowed the gap in outcome between black and white pediatric patients. Patients and Methods: In a parallel comparison, we analyzed survival by disease category between black and white patients with childhood cancer registered in one of the 17 cancer registries of the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) program or treated at St Jude Children's Research Hospital, which provides comprehensive treatment to all patients regardless of their ability to pay, from 1992 to 2000 and from 2001 to 2007. Results: Analysis of the SEER data indicated that in both study periods, black patients had significantly poorer rates of survival than did white patients, with the exception of a few types of cancer. Despite significantly improved treatment outcomes for patients who were treated from 2001 to 2007, the racial difference in survival has actually widened for acute myeloid leukemia and neuroblastoma. By contrast, in the cohorts treated at St Jude Children's Research Hospital, there were no significant differences in survival between black and white patients in either study period, regardless of the cancer type. Importantly, the outcome of treatment for acute lymphoblastic leukemia, acute myeloid leukemia, and retinoblastoma has improved in parallel for both races during the most recent study period. Conclusion: With equal access to comprehensive treatment, black and white children with cancer can achieve the same high cure rates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma
Yu, A. L., Gilman, A. L., Ozkaynak, M. F., London, W. B., Kreissman, S. G., Chen, H. X., Smith, M., Anderson, B., Villablanca, J. G., Matthay, K. K., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0911123 · Cited by 1,835 · cited 1×
“Immunotherapy with the monoclonal antibody anti-GD2 with granulocyte-macrophage colony-stimulating factor, interleukin-2, and isotretinoin has also significantly improved the survival of patients with high-risk neuroblastoma treated in a recent COG study.(38) These therapeutic gains have benefited black and white chil…”
BackgroundOutcomes for children and adolescents with cancer: challenges for the twenty-first century
Smith, M. A., Seibel, N. L., Altekruse, S. F., Ries, L. A. G., Melbert, D. L., O'Leary, M., Smith, F. O., & Reaman, G. H. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.0421 · Cited by 1,026
Racial disparities in incidence and outcome in multiple myeloma: a population-based study
Waxman, A. J., Mink, P. J., Devesa, S. S., Anderson, W. F., Weiss, B. M., Kristinsson, S. Y., McGlynn, K. A., & Landgren, O. (2010) · Blood · doi:10.1182/blood-2010-07-298760 · Cited by 411
Linabery, A. M., & Ross, J. A. (2008) · Cancer · doi:10.1002/cncr.23866 · Cited by 246
Cited by
Childhood and adolescent cancer statistics, 2014
Ward, E., DeSantis, C., Robbins, A., Kohler, B., & Jemal, A. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21219 · Cited by 2,412
Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?
Pui, C.-H., Mullighan, C. G., Evans, W. E., & Relling, M. V. (2012) · Blood · doi:10.1182/blood-2012-05-378943 · Cited by 500
Self-citationThe UCSC Cancer Genomics Browser: update 2015
Goldman, M., Craft, B., Swatloski, T., Cline, M., Morozova, O., Diekhans, M., Haussler, D., & Zhu, J. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1073 · Cited by 371
A 50-Year Journey to Cure Childhood Acute Lymphoblastic Leukemia
Pui, C.-H., & Evans, W. E. (2013) · Seminars in Hematology · doi:10.1053/j.seminhematol.2013.06.007 · Cited by 368
Self-citationEpidemiology and Etiology of Leukemia and Lymphoma
Bispo, J. A. B., Pinheiro, P. S., & Kobetz, E. K. (2020) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a034819 · Cited by 319
Metadata
- Authors
- Pui, C.-H., Pei, D., Pappo, A. S., Howard, S. C., Cheng, C., Sandlund, J. T., Furman, W. L., Ribeiro, R. C., Spunt, S. L., Rubnitz, J. E., Jeha, S., Hudson, M. M., Kun, L. E., Merchant, T. E., Kocak, M., Broniscer, A., Metzger, M. L., Downing, J. R., Leung, W., Evans, W. E., & Gajjar, A.
- Venue
- Journal of Clinical Oncology
- Published
- 2012-06-01
- Volume
- 30
- Issue
- 16
- Pages
- 2005-2012
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2136641592
- Cited by
- 128
- References
- 4
- FWCI
- 6.53
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treatment Outcomes in Black and White Children With Cancer: Results From the SEER Database and St Jude Children's Research Hospital, 1992 Through 2007. https://app.cochat.ai/papers/10.1200/jco.2011.40.8617
- The paper
- Pui, C.-H., Pei, D., Pappo, A. S., Howard, S. C., Cheng, C., Sandlund, J. T., Furman, W. L., Ribeiro, R. C., Spunt, S. L., Rubnitz, J. E., Jeha, S., Hudson, M. M., Kun, L. E., Merchant, T. E., Kocak, M., Broniscer, A., Metzger, M. L., Downing, J. R., Leung, W., . . . Gajjar, A. (2012). Treatment Outcomes in Black and White Children With Cancer: Results From the SEER Database and St Jude Children's Research Hospital, 1992 Through 2007. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2011.40.8617
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.